Table 2.

Treatment-related adverse events

	Grades 1–2	Grades 3–5
Neutropaenia	16 (32.0%)	10 (20.0%)
Anaemia	14 (28.0%)	4 (8.0%)
Rash	16 (32.0%)	0
Hepatic dysfunction	10 (20.0%)	2 (4.0%)
Thrombocytopaenia	7 (14.0%)	4 (8.0%)
Nausea	13 (26.0%)	0
Pulmonary infection	3 (6.0%)	2 (4.0%)
Renal dysfunction	4 (8.0%)	1 (2.0%)
Thyroid dysfunction	1 (2.0%)	0
Pulmonary embolism	0	1 (2.0%)
Fever	2 (4.0%)	1 (1.0%)
Febrile neutropaenia	0	1 (2.0%)
Haemoptysis	2 (4.0%)	1 (2.0%)
Atrial fibrillation	2 (4.0%)	0
Paresthaesia	2 (4.0%)	0
Hiccup	1 (2.0%)	0
Diarrhoea	1 (2.0%)	0